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We herein report a case of large intracardiac thrombus in a child with SARS-CoV-2
infection (COVID-19). The diagnosis of COVID-19 was confirmed through HRCT and
RT-PCR. Transthoracic echocardiography revealed a large thrombus in the right atrium
treated successfully via cardiac surgery. The underlying mechanisms of this thrombus
in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory
condition incurred by the COVID-19 virus.
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INTRODUCTION
In December 2019, an outbreak of new viral pneumonia caused by the novel coronavirus
(SARS-CoV-2) occurred in Wuhan, China (1). This virus is responsible for COVID-19 (Corona
Virus Disease 2019) and can lead to different symptoms ranging from a mild viral disease to
acute respiratory distress syndrome (ARDS), multi-organ failure, and death (2, 3). Although
cardiovascular complications of COVID-19 has been well-described in the current literature,
intracardiac thrombus complication in children has been rarely reported. Intracardiac thrombus
caused by SARS-CoV-2 infection is a serious and life-threatening complication in COVID-19
patients (4) and the size of thrombus at the time of diagnosis correlates strongly with increased
risk of thromboembolism and sudden death (5). Here, we describe a case report of large thrombus
formation in the right atrium (RA) of a child with COVID-19 infection required emergency cardiac
surgery, as the only preferred treatment to remove such a large thrombus.
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On 7 April 2020, an 11-years-old boy was admitted to the
pediatric hospital in Esfahan with high fever, dyspnea, and
skin rashes. Past medical history of patient showed that he
was a known case of seizure disorder and neurodevelopmental
delay, and had been under treatment with phenobarbital.
Blood gas analysis on the admission time showed a pH of
7.27, pCO2 of 49.5 mmHg, pO2 of 44.8 mmHg, and oxygen
saturation (O2 Sat) of 73%. Also, his laboratory test results
were as follows: white blood cell count (WBC) of 11.4 ×
10∗9/L (reference range: 4.5–11), C-reactive protein (CRP) 38
mg/dL (reference range: up to 6), erythrocyte sedimentation
FIGURE 1 | High-resolution computed tomography (HRCT) of the lungs in
COVID-19 child showing bilateral multiple patchy areas of ground glass
opacities.
TABLE 1 | Laboratory test results of patient during the course of disease.
Variables Reference range Admission Day 5 Day 10 Before surgery After surgery
RBC count (×10*12/L) 4.5–6.5 3.84 4.04 4.13 3.88 4.63
Hematocrit (%) 41–51 36.9 38.3 38.4 31.6 41.3
Hemoglobin (g/dL) 13–17 11.5 12.5 13.3 10.9 14.5
WBC (×10*9/L) 4.5–11 11.4 12.2 13.5 21.3 11.2
Lymphocyte count (%) 20–40 27 15 16 15.1 17.5
Neutrophil count (%) 50–70 66.4 78 72.1 75.7 72.9
Platelet count (×10*9/L) 150–450 252 279 247 400 238
PT (second) 11–13 13 12.8 12.2 17.1 16
PTT (second) 26–45 38 37 33 30 28
INR 0.8–1.2 1.1 1.1 1.1 1.4 1.2
Blood culture (×3) + / - - - - - -
RBC, red blood cell; WBC, white blood cell; PT, prothrombin time; PTT, partial thromboplastin time; INR, international normalized ratio.
rate (ESR) 38 mm/h (reference range: up to 20), and lactate
dehydrogenase (LDH) 427 U/L (reference range: 140–280).
Chest x-ray and high-resolution computed tomography (HRCT)
showed typical ground-glass opacitiesin both lungs, suggesting
viral pneumonia (Figure 1). Throat swab samples analysis by
reverse transcription-polymerase chain reaction (RT-PCR)
confirmed COVID-19 infection and treatment of disease was
started according to the Iranian pediatric protocol including
hydroxychloroquine (5 mg/kg/dose), lopinavir /ritonavir (230
mg/m2/dose), ceftriaxone (75 mg/kg/dose), and vancomycin (10
mg/kg/dose) (6). On the 2nd day of hospitalization, he presented
shortness of breathing and decreased level of consciousness
(LOC) that led to intubation and he put on a ventilator.
After extubation, Bi-level positive airway pressure (BiPAP)
was administrated for respiratory support. Despite receiving
drug treatment for COVID-19, his laboratory test results
were significant for continuous leukocytosis and neutrophilia
(Table 1). Because of persistent fever and tachycardia, pediatric
cardiology consultation was requested and transthoracic
echocardiography revealed a large mobile homogenous mass (2.5
× 1.5 cm) on the tricuspid valve leaflet extended to the RA and
right ventricle (RV) with attachment to the tip of central venous
catheter (CVC) that was in favor of thrombus or vegetation
(Figure 2). Besides, trivial tricuspid regurgitation (TR) and
trivial pulmonary insufficiency (PI) were found. Consequently,
he was transferred to the ChamranHeart Center on 16 April 2020
for surgical intervention. A sternotomy with cardiopulmonary
bypass was performed and intraoperative observations revealed
a large thrombus in RA which was removed completely together
with CVC while cardiac valves were preserved (Figure 3). After
the surgery, he was admitted to the ICU, and the pediatric
ward thereafter. Culture result of the thrombus showed no
fungal and bacterial infection and also SARS-CoV-2 RNA
was not detected in the mass. Histological analysis of the
mass showed inflammatory infiltrate (mostly neutrophils)
formation along with organizing thrombus and partial necrosis
of tricuspid valve leaflet. He was discharged after 2 weeks in good
health condition.
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FIGURE 2 | Transthoracic echocardiogram showing a large 2.5 × 1.5 cm
mass on tricuspid valve leaflet protruded to the right atrium and right ventricle.
DISCUSSION
Accumulating evidence has indicated cardiovascular
involvement of COVID-19 infection which can lead to the
poor clinical prognosis of this disease. Discriminating between a
cardiac or pulmonary cause of symptoms can be difficult because
each may present mostly with dyspnea. Recent reports have
shown that COVID-19 is associated with the increased incidence
of cardiovascular complications including myocarditis, acute
cardiac injury, and arrhythmias (7). Moreover, it has been
demonstrated that inflammation and thrombosis mutually
reinforce each other and COVID-19 infection can lead to the
coagulopathy likely due to infection-induced inflammatory
changes (8). Remarkable inflammation is observed in patients
with COVID-19 infection presenting by elevated levels of
IL-6, increased CRP and erythrocyte sedimentation rate (ESR).
This inflammatory condition and subsequent activation of
coagulation are the probable causes for the hypercoagulable
state in COVID-19 infection (9). The intracardiac thrombus
formation has rarely been described in the COVID-19 patients
and our finding supports current reports that indicate higher
thrombotic risk in COVID-19 patients (10, 11). The presence
of a large thrombus in RA was an unexpected finding in
our case because he had no history of heart disease or
coagulopathy. Similar to the other reports, we believe that
the bigger the size of the clot, the greater the chance that medical
treatment will fail (12). Removal of such a large thrombus
needs surgical intervention and surgical thrombectomy should
be opted to treat large right atrial thrombus (more than
2 cm) in the absence of any contraindication for surgery. In
parallel with us, a literature review by Negulescu et al. has
FIGURE 3 | Formation of a large thrombus around the CVC that was removed
along with catheter via open heart surgery.
reported a lower mortality rate in the surgical intervention
compared to the anticoagulation treatment. Meanwhile,
anticoagulation treatment correlates with the theoretical risk
of lysed clots lodging in pulmonary arteries and consequent
pulmonary thromboembolism (13). In conclusion, there
is an increasing concern about hypercoagulation and
acute thrombosis in patients with COVID-19 infection.
Therefore, conservative treatment with anticoagulation along
with vigilant observation is recommended in all COVID-
19 patients to prevent subsequent hypercoagulation and
thrombus formation.
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